The sensitivity and efficacy method of PIK3CA exon 9 E545A as a high diagnostic accuracy in breast cancer

J. Dunlap, C. Le, A. Shukla, J. Patterson, A. Presnell, M.C. Heinrich, L. Christipher, L. Corless, Megan L. Troxell. Phosphatiylinositol-3-kinase and AKT1 mutations occur early in breast cancer carcinoma. Breast Cancer Treat 2010;120:409–418. Dieci, 2015, PIK3CA: a Target or a marker in breast cancers, Curr Breast Cancer Rep, 7, 1, 10.1007/s12609-015-0184-1 Arthur, 2014, Changes in PIK3CA mutation status are not associated with recurrence, metastasic disease or progression in endocrine trated breast cancer, Breast Cancer Res Treat, 147, 211, 10.1007/s10549-014-3080-x Miller, 2011, Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer, Breast Cancer Res, 13, 224, 10.1186/bcr3039 Mukohara, 2015, PI3K mutations in breast cancer: prognostic and therapeutic implications, Breast Cancer (Dove Med Press), 7, 111 Samuels, 2004, High frequency of mutation of the PIK3CA gene in human cancers, Science, 304, 554, 10.1126/science.1096502 Samuels, 2010, Oncogenic mutations of PIK3CA in human cancers, Curr Top Microbiol Immunol, 347, 21 Jiang, 2010, PI3K/PTEN signaling in angiogenesis and tumorigenesis, Adv Cancer Res, 102, 19, 10.1016/S0065-230X(09)02002-8 Meyer, 2011, Luminal expression of pIK3CA mutant H1047R in the mammary gland induces heterogenous tumors, Can Res, 71, 4344, 10.1158/0008-5472.CAN-10-3827 Mayer, 2015, Clinical implications of mutations in the PIK3 pathway in HER-2+ breast cancer: prognostic of predictive?, Curr Breast Cancer Rep, 7, 210, 10.1007/s12609-015-0197-9 Gymnopoulos M, Elsiger MA, Vogt PK. Rare cancer -specific mutations in PIK3CA Show gain of function 2007;104:5569–74. Liang, 2006, Mutational hotspot in exon 20 of PIK3CA in breast cancer among Singapore Chinese, Cancer Biol Ther, 5, 544, 10.4161/cbt.5.5.2656 Castaneda CA, Lopez-Ilasaca M, Pinto JA, Chirinos-Arias M, Doimi F, Neciosup SP, Rojas KI, Vidaurre T, Balko JM, Arteaga CL, Gomez HL. PIK3CA mutations in Peruvian Patients with HER-2 amplified and triple negative non mteatatic breast cancers. Hematol Oncol Stem Cell Ther 2014;7:142–8. Zhu, 2012, PI3K expression and PIK3CA mutation are related to colorectal cancer metastases, World J Gastroenterol, 28, 3745, 10.3748/wjg.v18.i28.3745 Kompier, 2010, FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy, PLoS ONE, 5, 1, 10.1371/journal.pone.0013821 Baker, 2011, A PIK3CA Pyrosequencing based assay that excludes pseudogene interference, J Mol Diagn, 14, 56, 10.1016/j.jmoldx.2011.08.004 Schneck, 2013, Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients, Molecul Oncol, 976–986 Al-Ahwani, 2016, Method development for detection of E545A mutation PIK3CA gene in breast cancer patients using Tm Shift SYBR Green I qPCR, Indoens J Biotechnol, 21, 22, 10.22146/ijbiotech.26815 Chan, 2016, Using pooled recombinant plasmid as control materials for diagnostic real-time PCR, Clin Lab, 61, 1893 Sims, 2015, Plasmid Based Material as multiplex quality controls and calibrators for clinical next generation sequencing assay, J Mol Diagn, 18, 335 Bachman, 2004, The PIK3CA gene is mutated with high frequency in humans breast cancers, Cancer Biol Ther, 3, 772, 10.4161/cbt.3.8.994 Germer, 1999, Single-tube genotyping without oligonucleotide probes, Genome Res, 9, 72, 10.1101/gr.9.1.72 Rasmussen, 2007, Use of DNA melting simulation software for in silico diagnostic assay design: targeting regions with complex melting curves and confirmation by real-time PCR using intercalating dyes, BMC Bioinformat, 8, 107, 10.1186/1471-2105-8-107 Liu, 2012, An improved allele-specific PCR primer design method for SNP marker analysis and its application, Plant Meth, 8, 1, 10.1186/1746-4811-8-34 Bustin, 2009, The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments, Clin Chem, 55, 1, 10.1373/clinchem.2008.112797 Dorak, 2006